Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Sanofi reports tachykinin antagonists

Sep. 27, 1996

Glutamate inhibitor progresses through the pipeline

Sep. 20, 1996

Another series of mGluR antagonists from Lilly

Sep. 20, 1996

Metabotropic glutamate receptor antagonists from Lilly

Sep. 20, 1996

Metabotropic glutamate antagonists from Novo Nordisk

Sep. 20, 1996

Forest prepares submission for Alzheimer's disease product

Sep. 20, 1996

Bayer patents new compounds for CNS disorders

Sep. 20, 1996

Antiemetic 5-HT3 antagonist launched in Japan

Sep. 20, 1996

Roquinimex in MS

Sep. 20, 1996

Idebenone evaluated in Huntington's disease

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...